Ally Bridge Group’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-12,180
Closed -$2.06M 35
2022
Q4
$2.06M Sell
12,180
-4,544
-27% -$824K 2.01% 21
2022
Q3
$3.13M Buy
+16,724
New +$3.53M 2.07% 21
2022
Q1
Sell
-70,000
Closed -$18.5M 27
2021
Q4
$18.5M Hold
70,000
6.48% 3
2021
Q3
$20.2M Sell
70,000
-12,500
-15% -$3.21M 5.95% 3
2021
Q2
$16.5M Hold
82,500
4.09% 9
2021
Q1
$16M Hold
82,500
3.08% 10
2020
Q4
$15.8M Buy
+82,500
New +$15M 2.71% 11

Other funds holding RGEN

Ally Bridge Group's RGEN Position: Q1 2023 in Review

Ally Bridge Group sold out of Repligen (RGEN) in Q1 2023, closing a stake of 12,180 shares — an estimated $2.06M sold.

Ally Bridge Group first reported a position in RGEN in Q4 2020 and held it in 7 quarters. The position peaked at $20.2M in Q3 2021. 446 funds tracked by Wall St. Rank hold RGEN as of Q1 2023.

  • Ally Bridge Group reported no remaining Repligen position as of Q1 2023 after selling out during the quarter.
  • Ally Bridge Group sold 12,180 Repligen shares in Q1 2023, an estimated $2.06M.
  • Ally Bridge Group first reported a position in Repligen in Q4 2020 and held it in 7 quarters.
  • Ally Bridge Group's Repligen position peaked at $20.2M in Q3 2021.
  • 446 funds tracked by Wall St. Rank held Repligen as of Q1 2023.

Based on Ally Bridge Group's 13F filing for Q1 2023, filed 15 May 2023.